DELMONTE, ANNAMARIA
DELMONTE, ANNAMARIA
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)
2024 Pizzutilo, E G; Agostara, A G; Oresti, S; Signorelli, D; Stabile, S; Lauricella, C; Motta, V; Amatu, A; Ruggieri, L; Brambilla, M; Occhipinti, M; Proto, C; Giusti, R; Filetti, M; Genova, C; Barletta, G; Gelsomino, F; Bennati, C; Siringo, M; Di Fazio, G R; Russano, M; Montrone, M; Gariazzo, E; Roca, E; Bordi, P; Delmonte, A; Scimone, A; Belluomini, L; Mazzoni, F; Carta, A; Pelizzari, G; Viscardi, G; Morgillo, F; Gelibter, A; Gori, S; Berardi, R; Cortinovis, D; Ardizzoni, A; Veronese, S M; Sartore-Bianchi, A; Giannetta, L G; Cerea, G; Siena, S
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3)
2021 Gelsomino F.; Tiseo M.; Barbieri F.; Riccardi F.; Cavanna L.; Frassoldati A.; Delmonte A.; Longo L.; Dazzi C.; Cinieri S.; Colantonio I.; Sperandi F.; Lamberti G.; Brocchi S.; Tofani L.; Boni L.; Ardizzoni A.
ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
2020 Chiari R.; Ricciuti B.; Landi L.; Morelli A.M.; Delmonte A.; Spitaleri G.; Cortinovis D.L.; Lamberti G.; Facchinetti F.; Pilotto S.; Verusio C.; Chella A.; Bonanno L.; Galetta D.; Cappuzzo F.
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience
2019 Rihawi K ; Giannarelli D ; Galetta D ; Delmonte A ; Giavarra M ; Turci D ; Garassino M ; Tiseo M ; Barbieri ; Panni S ; Ardizzoni A;
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population
2019 Crino, L.; Bidoli, P.; Delmonte, A.; Grossi, F.; De Marinis, F.; Ardizzoni, A.; Vitiello, F.; Lo Russo, G.; Parra, H. S.; Cortesi, E.; Cappuzzo, F.; Calabro, L.; Tiseo, M.; Turci, D.; Gamucci, T.; Antonelli, P.; Morabito, A.; Chella, A.; Giannarelli, D.; Galetta, D.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO) | Pizzutilo, E G; Agostara, A G; Oresti, S; Signorelli, D; Stabile, S; Lauricella, C; Motta, V; Ama...tu, A; Ruggieri, L; Brambilla, M; Occhipinti, M; Proto, C; Giusti, R; Filetti, M; Genova, C; Barletta, G; Gelsomino, F; Bennati, C; Siringo, M; Di Fazio, G R; Russano, M; Montrone, M; Gariazzo, E; Roca, E; Bordi, P; Delmonte, A; Scimone, A; Belluomini, L; Mazzoni, F; Carta, A; Pelizzari, G; Viscardi, G; Morgillo, F; Gelibter, A; Gori, S; Berardi, R; Cortinovis, D; Ardizzoni, A; Veronese, S M; Sartore-Bianchi, A; Giannetta, L G; Cerea, G; Siena, S | 2024-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | 1-s2.0-S2059702924013619-main.pdf; 1-s2.0-S2059702924013619-mmc1.docx |
| Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3) | Gelsomino F.; Tiseo M.; Barbieri F.; Riccardi F.; Cavanna L.; Frassoldati A.; Delmonte A.; Longo ...L.; Dazzi C.; Cinieri S.; Colantonio I.; Sperandi F.; Lamberti G.; Brocchi S.; Tofani L.; Boni L.; Ardizzoni A. | 2021-01-01 | BRITISH JOURNAL OF CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS) | Chiari R.; Ricciuti B.; Landi L.; Morelli A.M.; Delmonte A.; Spitaleri G.; Cortinovis D.L.; Lambe...rti G.; Facchinetti F.; Pilotto S.; Verusio C.; Chella A.; Bonanno L.; Galetta D.; Cappuzzo F. | 2020-01-01 | CLINICAL LUNG CANCER | - | 1.01 Articolo in rivista | - |
| BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience | Rihawi K ; Giannarelli D ; Galetta D ; Delmonte A ; Giavarra M ; Turci D ; Garassino M ; Tiseo M... ; Barbieri ; Panni S ; Ardizzoni A; | 2019-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population | Crino, L.; Bidoli, P.; Delmonte, A.; Grossi, F.; De Marinis, F.; Ardizzoni, A.; Vitiello, F.; Lo ...Russo, G.; Parra, H. S.; Cortesi, E.; Cappuzzo, F.; Calabro, L.; Tiseo, M.; Turci, D.; Gamucci, T.; Antonelli, P.; Morabito, A.; Chella, A.; Giannarelli, D.; Galetta, D. | 2019-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |